Cargando…
Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and autism. FXS is also accompanied by attention problems, hyperactivity, anxiety, aggression, poor sleep, repetitive behaviors, and self-injury. Recent work supports the role of γ-aminobutyric-acid (GABA), the pri...
Autores principales: | Cogram, Patricia, Deacon, Robert M. J., Warner-Schmidt, Jennifer L., von Schimmelmann, Melanie J., Abrahams, Brett S., During, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603241/ https://www.ncbi.nlm.nih.gov/pubmed/31293404 http://dx.doi.org/10.3389/fnbeh.2019.00141 |
Ejemplares similares
-
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
por: Altimiras, Francisco, et al.
Publicado: (2021) -
Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
por: Gurney, Mark E., et al.
Publicado: (2017) -
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
por: Budimirovic, Dejan B., et al.
Publicado: (2021) -
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
por: Bird, Lynne M., et al.
Publicado: (2021) -
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
por: Cogram, Patricia, et al.
Publicado: (2020)